Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Risk Reduction|Breast Cancer
Interventions: DRUG: Bazedoxifene and Conjugated Estrogens
Sponsor: University of Kansas Medical Center
Collaborators: National Cancer Institute (NCI)